Clinical trial
Thiamine as Adjunctive Therapy for Diabetic Ketoacidosis
NCT03717896 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thiamine as Adjunctive Therapy for Diabetic Ketoacidosis
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 21, 2018
- Completion date
- October 1, 2024
- Enrollment
- 102 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.